ROIV Relative Valuation
ROIV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ROIV is overvalued; if below, it's undervalued.
Historical Valuation
Roivant Sciences Ltd (ROIV) is now in the Undervalued zone, suggesting that its current forward PS ratio of 20.57 is considered Undervalued compared with the five-year average of -7.28. The fair price of Roivant Sciences Ltd (ROIV) is between 35.35 to 141.10 according to relative valuation methord. Compared to the current price of 20.62 USD , Roivant Sciences Ltd is Undervalued By 41.66%.
Relative Value
Fair Zone
35.35-141.10
Current Price：20.62
41.66%
Undervalued
-14.64
PE
1Y
3Y
5Y
Trailing
Forward
-8.57
EV/EBITDA
Roivant Sciences Ltd. (ROIV) has a current EV/EBITDA of -8.57. The 5-year average EV/EBITDA is -3.12. The thresholds are as follows: Strongly Undervalued below -7.99, Undervalued between -7.99 and -5.56, Fairly Valued between -0.69 and -5.56, Overvalued between -0.69 and 1.74, and Strongly Overvalued above 1.74. The current Forward EV/EBITDA of -8.57 falls within the Strongly Undervalued range.
-9.37
EV/EBIT
Roivant Sciences Ltd. (ROIV) has a current EV/EBIT of -9.37. The 5-year average EV/EBIT is -2.66. The thresholds are as follows: Strongly Undervalued below -8.28, Undervalued between -8.28 and -5.47, Fairly Valued between 0.15 and -5.47, Overvalued between 0.15 and 2.96, and Strongly Overvalued above 2.96. The current Forward EV/EBIT of -9.37 falls within the Strongly Undervalued range.
20.62
PS
Roivant Sciences Ltd. (ROIV) has a current PS of 20.62. The 5-year average PS is 71.38. The thresholds are as follows: Strongly Undervalued below -60.47, Undervalued between -60.47 and 5.45, Fairly Valued between 137.31 and 5.45, Overvalued between 137.31 and 203.23, and Strongly Overvalued above 203.23. The current Forward PS of 20.62 falls within the Historic Trend Line -Fairly Valued range.
-18.84
P/OCF
Roivant Sciences Ltd. (ROIV) has a current P/OCF of -18.84. The 5-year average P/OCF is -9.43. The thresholds are as follows: Strongly Undervalued below -31.50, Undervalued between -31.50 and -20.47, Fairly Valued between 1.61 and -20.47, Overvalued between 1.61 and 12.64, and Strongly Overvalued above 12.64. The current Forward P/OCF of -18.84 falls within the Historic Trend Line -Fairly Valued range.
-12.89
P/FCF
Roivant Sciences Ltd. (ROIV) has a current P/FCF of -12.89. The 5-year average P/FCF is -7.46. The thresholds are as follows: Strongly Undervalued below -18.32, Undervalued between -18.32 and -12.89, Fairly Valued between -2.03 and -12.89, Overvalued between -2.03 and 3.40, and Strongly Overvalued above 3.40. The current Forward P/FCF of -12.89 falls within the Historic Trend Line -Fairly Valued range.
Roivant Sciences Ltd (ROIV) has a current Price-to-Book (P/B) ratio of 3.23. Compared to its 3-year average P/B ratio of 3.72 , the current P/B ratio is approximately -13.26% higher. Relative to its 5-year average P/B ratio of 2.97, the current P/B ratio is about 8.56% higher. Roivant Sciences Ltd (ROIV) has a Forward Free Cash Flow (FCF) yield of approximately -6.04%. Compared to its 3-year average FCF yield of -10.73%, the current FCF yield is approximately -43.67% lower. Relative to its 5-year average FCF yield of -30.24% , the current FCF yield is about -80.02% lower.
3.24
P/B
Median3y
3.72
Median5y
2.97
-6.03
FCF Yield
Median3y
-10.73
Median5y
-30.24
Competitors Valuation Multiple
The average P/S ratio for ROIV's competitors is 134.21, providing a benchmark for relative valuation. Roivant Sciences Ltd Corp (ROIV) exhibits a P/S ratio of 20.62, which is -84.64% above the industry average. Given its robust revenue growth of -72.84%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ROIV increased by 62.23% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -395.53 to -12.62K.
The secondary factor is the Revenue Growth, contributed -72.84%to the performance.
Overall, the performance of ROIV in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Roivant Sciences Ltd (ROIV) currently overvalued or undervalued?
What is Roivant Sciences Ltd (ROIV) fair value?
How does ROIV's valuation metrics compare to the industry average?
What is the current P/B ratio for Roivant Sciences Ltd (ROIV) as of Nov 09 2025?
What is the current FCF Yield for Roivant Sciences Ltd (ROIV) as of Nov 09 2025?
What is the current Forward P/E ratio for Roivant Sciences Ltd (ROIV) as of Nov 09 2025?